Mead Johnson Nutrition (MJN) Set to Announce Quarterly Earnings on Thursday
Mead Johnson Nutrition (NYSE:MJN) is set to announce its Q313 earnings results on Thursday, October 24th. Analysts expect the company to announce earnings of $0.79 per share and revenue of $998.04 million for the quarter. Mead Johnson Nutrition has set its FY13 guidance at $3.20-3.30 EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.
Mead Johnson Nutrition (NYSE:MJN) last released its earnings data on Thursday, July 25th. The company reported $0.84 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.83 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.04 billion. During the same quarter last year, the company posted $0.83 earnings per share. Mead Johnson Nutrition’s revenue was up 4.2% compared to the same quarter last year.
Mead Johnson Nutrition (NYSE:MJN) opened at 81.34 on Wednesday. Mead Johnson Nutrition has a 52-week low of $61.27 and a 52-week high of $86.87. The stock’s 50-day moving average is $75.6 and its 200-day moving average is $77.18. The company has a market cap of $16.462 billion and a P/E ratio of 26.99.
A number of analysts have recently weighed in on MJN shares. Analysts at Citigroup Inc. upgraded shares of Mead Johnson Nutrition from a “neutral” rating to a “buy” rating in a research note to investors on Monday. They now have a $95.00 price target on the stock, up previously from $77.00. On the ratings front, analysts at Deutsche Bank reiterated a “buy” rating on shares of Mead Johnson Nutrition in a research note to investors on Wednesday, October 16th. They now have a $86.00 price target on the stock. Finally, analysts at Credit Suisse reiterated an “outperform” rating on shares of Mead Johnson Nutrition in a research note to investors on Thursday, October 3rd. Eleven investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Mead Johnson Nutrition currently has an average rating of “Hold” and an average target price of $81.51.
In other Mead Johnson Nutrition news, Director Stephen Golsby unloaded 10,000 shares of Mead Johnson Nutrition stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $75.28, for a total transaction of $752,800.00. Following the completion of the transaction, the director now directly owns 90,172 shares of the company’s stock, valued at approximately $6,788,148. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.